Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
Published Online: 2025-01-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Abby B Siegel•Anthony B El-Khoueiry•Arndt Vogel•Chuan Li•Corina Dutcus•David C Madoff•Guohong Han•Hailan Lin•Haitao Zhao•Hiromitsu Kumada•Ji Hoon Kim•Jinfang Zheng•Josep M Llovet•Kalgi Mody•Leonid Dubrovsky•Masafumi Ikeda•Masatoshi Kudo•R Mark Ghobrial•René Gerolami•Richard S Finn•Sadahisa Ogasawara•Tomokazu Kawaoka•Xiang Peng•Yabing Guo•Zhenggang Ren
